An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

GEMTESA®

Drug Information Related Patent

Hold Company

UROVANT

Learn More

Dosage and Administration

TABLET;ORAL

Specification

75MG

Indication

GEMTESA® can be used to treat overactive bladder (OAB) in adults with urge urinary incontinence and frequent urination.

Use

Instructions for Use

API

VIBEGRON

API Structure

We Supply

VIBEGRON

Note:

null

Note:

null

Note:

null

Drug Patent

Patent No	Expiration Date
8247415	2030/12/1
8653260	2029/4/2

API Patent

Patent No	Expiration Date
8247415	2030/12/1
8653260	2029/4/2

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Tel:
E-mail:
Address:
WhatsAPP

Member of

CERTIFICATION